Related Experiment Video
Updated: May 21, 2025
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.7K
Tuberculosis in Poland in 2022
Maria Joanna Korzeniewska-Koseła1, Stefan Wesołowski2
1Zakład Epidemiologii i Organizacji Walki z Gruźlicą, Instytut Gruźlicy i Chorób Płuc, Warszawa.
Przeglad Epidemiologiczny
|March 18, 2025
Summary
Tuberculosis incidence in Poland increased by 17.5% in 2022, with higher rates in men and older adults. Poland shows better bacteriological confirmation and lower multidrug-resistant tuberculosis rates than EU/EEA countries.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a significant global health challenge.
- Understanding current TB epidemiology is crucial for effective control strategies.
Purpose of the Study:
- To analyze the 2022 tuberculosis epidemiology in Poland.
- To compare Poland's TB data with European Union and European Economic Area (EU/EEA) countries.
Main Methods:
- Analysis of registered TB cases in Poland for 2022.
- Inclusion of drug susceptibility results and mortality data.
- Comparison with European Centre for Disease Prevention and Control (ECDC) reports.
Main Results:
- Poland registered 4314 TB cases in 2022 (11.4 per 100,000), a 17.5% increase from 2021.
- Bacteriological confirmation rate was 81.9%, higher than the EU/EEA average (70.6%).
- Multidrug-resistant TB (MDR-TB) was lower in Poland (3.1%) compared to EU/EEA (4.4%).
Conclusions:
- TB incidence in Poland is rising, particularly among older males.
- Poland demonstrates strengths in TB case confirmation and lower MDR-TB rates compared to EU/EEA.
- Data gaps in HIV co-infection and treatment outcomes require attention for comprehensive TB control.
Related Concept Videos
01:28Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
01:29Pulmonary Tuberculosis I
214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
01:28Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
01:26Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
01:31Pulmonary Tuberculosis III
283
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
283
01:17Other Pulmonary Disorders
789
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
789